MCM
NVO

McKinley Capital Management’s Novo Nordisk NVO Stock Holding History

McKinley Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$3.32M Buy
23,228
+3,893
+20% +$516K 0.58% 48
2024
Q1 		$2.48M Buy
19,335
+8,751
+83% +$1.04M 0.3% 93
2023
Q4 		$1.09M Buy
10,584
+4,654
+78% +$460K 0.14% 119
2023
Q3 		$539K Sell
5,930
-1,044
-15% -$92K 0.08% 146
2023
Q2 		$564K Sell
6,974
-1,278
-15% -$104K 0.08% 148
2023
Q1 		$657K Sell
8,252
-660
-7% -$46.8K 0.09% 145
2022
Q4 		$603K Sell
8,912
-354
-4% -$20.8K 0.08% 151
2022
Q3 		$462K Sell
9,266
-484
-5% -$25.9K 0.06% 159
2022
Q2 		$543K Sell
9,750
-1,732
-15% -$96.1K 0.07% 159
2022
Q1 		$637K Buy
11,482
+154
+1% +$7.9K 0.06% 156
2021
Q4 		$635K Buy
11,328
+76
+0.7% +$4.12K 0.06% 163
2021
Q3 		$540K Buy
+11,252
New +$544K 0.05% 166
2021
Q1 		– Sell
-10,712
Closed -$374K – 188
2020
Q4 		$374K Sell
10,712
-5,530
-34% -$191K 0.03% 185
2020
Q3 		$564K Hold
16,242
– – 0.04% 165
2020
Q2 		$532K Sell
16,242
-872
-5% -$27.8K 0.04% 171
2020
Q1 		$515K Hold
17,114
– – 0.04% 162
2019
Q4 		$495K Buy
+17,114
New +$474K 0.03% 172
2018
Q2 		– Sell
-11,284
Closed -$278K – 330
2018
Q1 		$278K Sell
11,284
-1,048
-8% -$27.5K 0.02% 198
2017
Q4 		$331K Buy
+12,332
New +$314K 0.02% 263
2016
Q2 		– Sell
-5,944
Closed -$161K – 491
2016
Q1 		$161K Hold
5,944
– – 0.01% 307
2015
Q4 		$173K Sell
5,944
-49,342
-89% -$1.37M 0.01% 313
2015
Q3 		$1.5M Buy
55,286
+41,088
+289% +$1.16M 0.07% 194
2015
Q2 		$389K Sell
14,198
-694
-5% -$19.5K 0.02% 279
2015
Q1 		$398K Buy
+14,892
New +$343K 0.02% 269

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

McKinley Capital Management's NVO Position: Q2 2024 in Review

McKinley Capital Management increased its Novo Nordisk (NVO) stake by 20% in Q2 2024, buying an estimated $516K and bringing the position to 23,228 shares worth $3.32M. The position accounts for 0.58% of the portfolio, ranked #48.

McKinley Capital Management first reported a position in NVO in Q1 2015 and has held it in 24 quarters since. 1,864 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

  • McKinley Capital Management held 23,228 shares of Novo Nordisk worth $3.32M as of Q2 2024.
  • McKinley Capital Management bought 3,893 Novo Nordisk shares in Q2 2024, an estimated $516K.
  • Novo Nordisk made up 0.58% of McKinley Capital Management's portfolio in Q2 2024, its #48 holding.
  • McKinley Capital Management first reported a position in Novo Nordisk in Q1 2015 and has held it in 24 quarters since.
  • 1,864 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on McKinley Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.